#VisualAbstract: Adaptive versus conventional cardiac resynchronization therapy (CRT) in patients with heart failure
Click here to read this study in The Lancet ©2023 2 Minute Medicine, Inc. All rights reserved. No works may ...
Click here to read this study in The Lancet ©2023 2 Minute Medicine, Inc. All rights reserved. No works may ...
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The ...
1. Patients assigned to hemodynamic monitoring reported improved quality of life than those receiving contemporary guideline-directed medical therapy. 2. The ...
Vitamin D supplementation and major cardiovascular events: D-Health randomised controlled trial 1. In this randomized controlled trial, it was found ...
1. In this randomized controlled trial, patients who received transcatheter repair of mitral regurgitation secondary to cardiomyopathy had good safety ...
1. In this retrospective cohort study, glucagon-like peptide-1 receptor agonists (GLP1RA) were associated with a lower risk of major adverse ...
1. In this prespecified analysis of the DELIVER trial, among 6263 patients, dapagliflozin reduced the risk of total heart failure ...
1. In this longitudinal cohort study of 30 728 patients with diffuse large-B-cell lymphoma, preexisting heart failure at lymphoma diagnosis ...
1. One-quarter of top-performing quintile hospitals were reclassified to a lower performance group when Medicare Advantage beneficiaries were included compared ...
1. This cohort study showed significant variability in days alive out of hospital (DAOH) within one year of ventricular assist ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.